163 related articles for article (PubMed ID: 22113134)
21. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.
Harrop JA; McDonnell PC; Brigham-Burke M; Lyn SD; Minton J; Tan KB; Dede K; Spampanato J; Silverman C; Hensley P; DiPrinzio R; Emery JG; Deen K; Eichman C; Chabot-Fletcher M; Truneh A; Young PR
J Biol Chem; 1998 Oct; 273(42):27548-56. PubMed ID: 9765287
[TBL] [Abstract][Full Text] [Related]
22. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
24. Absence of herpes virus entry mediator (HVEM) increases bone mass by attenuating receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis.
Kim WK; Sul OJ; Choi EK; Lee MH; Jeong CS; Kim HJ; Kim SY; Suh JH; Yu R; Choi HS
Endocrinology; 2012 Oct; 153(10):4808-17. PubMed ID: 22865366
[TBL] [Abstract][Full Text] [Related]
25. Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses.
Haselmayer P; Tenzer S; Kwon BS; Jung G; Schild H; Radsak MP
Immunology; 2006 Nov; 119(3):404-11. PubMed ID: 17067315
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory and prothrombotic effects on human vascular endothelial cells of immune-cell-derived LIGHT.
Celik S; Shankar V; Richter A; Hippe HJ; Akhavanpoor M; Bea F; Erbel C; Urban S; Blank N; Wambsganss N; Katus HA; Dengler TJ
Eur J Med Res; 2009 Apr; 14(4):147-56. PubMed ID: 19380287
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
[TBL] [Abstract][Full Text] [Related]
28. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.
Zhai Y; Guo R; Hsu TL; Yu GL; Ni J; Kwon BS; Jiang GW; Lu J; Tan J; Ugustus M; Carter K; Rojas L; Zhu F; Lincoln C; Endress G; Xing L; Wang S; Oh KO; Gentz R; Ruben S; Lippman ME; Hsieh SL; Yang D
J Clin Invest; 1998 Sep; 102(6):1142-51. PubMed ID: 9739048
[TBL] [Abstract][Full Text] [Related]
29. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.
Mauri DN; Ebner R; Montgomery RI; Kochel KD; Cheung TC; Yu GL; Ruben S; Murphy M; Eisenberg RJ; Cohen GH; Spear PG; Ware CF
Immunity; 1998 Jan; 8(1):21-30. PubMed ID: 9462508
[TBL] [Abstract][Full Text] [Related]
30. Herpes Virus Entry Mediator (HVEM) Expression Promotes Inflammation/ Organ Injury in Response to Experimental Indirect-Acute Lung Injury.
Cheng T; Bai J; Chung CS; Chen Y; Fallon EA; Ayala A
Shock; 2019 Apr; 51(4):487-494. PubMed ID: 30531604
[TBL] [Abstract][Full Text] [Related]
31. Herpes Virus Entry Mediator (HVEM): A Novel Potential Mediator of Trauma-Induced Immunosuppression.
Wakeley ME; Shubin NJ; Monaghan SF; Gray CC; Ayala A; Heffernan DS
J Surg Res; 2020 Jan; 245():610-618. PubMed ID: 31522034
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
33. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract][Full Text] [Related]
34. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.
Ishida S; Yamane S; Ochi T; Nakano S; Mori T; Juji T; Fukui N; Itoh T; Suzuki R
J Rheumatol; 2008 Jun; 35(6):960-8. PubMed ID: 18412315
[TBL] [Abstract][Full Text] [Related]
35. Targeting the LIGHT-HVEM pathway.
Ware CF
Adv Exp Med Biol; 2009; 647():146-55. PubMed ID: 19760072
[TBL] [Abstract][Full Text] [Related]
36. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
Cai G; Freeman GJ
Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
[TBL] [Abstract][Full Text] [Related]
37. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
38. NADPH oxidase activation is required for migration by LIGHT in human monocytes.
Heo SK; Yun HJ; Park WH; Park SD
Biochem Biophys Res Commun; 2008 Jul; 371(4):834-40. PubMed ID: 18468509
[TBL] [Abstract][Full Text] [Related]
39. Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory.
Park JJ; Anand S; Zhao Y; Matsumura Y; Sakoda Y; Kuramasu A; Strome SE; Chen L; Tamada K
Cancer Immunol Immunother; 2012 Feb; 61(2):203-214. PubMed ID: 21877247
[TBL] [Abstract][Full Text] [Related]
40. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
